Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
about
Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes.Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects.Chemerin: a multifaceted adipokine involved in metabolic disorders.
P2860
Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pioglitazone and metformin are ...... patients with type 2 diabetes
@ast
Pioglitazone and metformin are ...... patients with type 2 diabetes
@en
type
label
Pioglitazone and metformin are ...... patients with type 2 diabetes
@ast
Pioglitazone and metformin are ...... patients with type 2 diabetes
@en
prefLabel
Pioglitazone and metformin are ...... patients with type 2 diabetes
@ast
Pioglitazone and metformin are ...... patients with type 2 diabetes
@en
P2093
P2860
P356
P1476
Pioglitazone and metformin are ...... patients with type 2 diabetes
@en
P2093
Alireza Esteghamati
Manouchehr Nakhjavani
Mehrnaz Ghasemiesfe
Sina Noshad
P2860
P304
P356
10.1111/JDI.12157
P577
2013-10-22T00:00:00Z